Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Stille delivered a Q1 ahead of our estimates across the board, with 19% organic growth and a 21.5% EBITDA margin.</li><li>The conference call reinforced our view of continued momentum, supported by ongoing supply chain improvements, solid underlying demand, and favourable comparables in Q2 and Q3.</li><li>We revise our base case modestly upward.</li></ul>

Stille delivered a Q1 ahead of our estimates across the board, with 19% organic growth and a 21.5% EBITDA margin.The conference call reinforced our view of continued momentum, supported by ongoing supply chain improvements, solid underlying demand, and favourable comparables in Q2 and Q3.We revise our base case modestly upward.

Stille (Q1 Review): Starting 2026 in style with momentum expected to continue